vs
MINERALS TECHNOLOGIES INC（MTX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是MINERALS TECHNOLOGIES INC的1.5倍（$772.1M vs $519.5M），Revvity净利率更高（12.7% vs 7.2%，领先5.6%），Revvity同比增速更快（5.9% vs 0.3%），Revvity自由现金流更多（$161.8M vs $31.9M），过去两年Revvity的营收复合增速更高（9.0% vs -1.4%）
康帕斯矿产国际是一家美国上市企业，作为领先的矿产生产商，主营盐、氯化镁、硫酸钾等产品，总部位于堪萨斯州欧弗兰帕克。公司为北美和英国客户提供经过处理及未经处理的散装道路除冰盐，同时为全球种植者提供植物营养产品，还生产民用除冰、水质调节类产品以及面向民用和商业场景的相关矿产品。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
MTX vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.5倍
$519.5M
营收增速更快
RVTY
高出5.6%
0.3%
净利率更高
RVTY
高出5.6%
7.2%
自由现金流更多
RVTY
多$129.9M
$31.9M
两年增速更快
RVTY
近两年复合增速
-1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $519.5M | $772.1M |
| 净利润 | $37.2M | $98.4M |
| 毛利率 | 24.0% | — |
| 营业利润率 | 11.9% | 14.5% |
| 净利率 | 7.2% | 12.7% |
| 营收同比 | 0.3% | 5.9% |
| 净利润同比 | -31.1% | 3.9% |
| 每股收益（稀释后） | $1.11 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTXRVTY
| Q4 25 | $519.5M | $772.1M | ||
| Q3 25 | $532.4M | $698.9M | ||
| Q2 25 | $528.9M | $720.3M | ||
| Q1 25 | $491.8M | $664.8M | ||
| Q4 24 | $518.1M | $729.4M | ||
| Q3 24 | $524.7M | $684.0M | ||
| Q2 24 | $541.2M | $691.7M | ||
| Q1 24 | $534.5M | $649.9M |
净利润MTXRVTY
| Q4 25 | $37.2M | $98.4M | ||
| Q3 25 | $43.0M | $46.7M | ||
| Q2 25 | $45.4M | $53.9M | ||
| Q1 25 | $-144.0M | $42.2M | ||
| Q4 24 | $54.0M | $94.6M | ||
| Q3 24 | $46.7M | $94.4M | ||
| Q2 24 | $19.7M | $55.4M | ||
| Q1 24 | $46.7M | $26.0M |
毛利率MTXRVTY
| Q4 25 | 24.0% | — | ||
| Q3 25 | 25.7% | 53.6% | ||
| Q2 25 | 25.9% | 54.5% | ||
| Q1 25 | 24.3% | 56.5% | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 25.8% | 56.3% | ||
| Q2 24 | 26.6% | 55.7% | ||
| Q1 24 | 25.4% | 54.6% |
营业利润率MTXRVTY
| Q4 25 | 11.9% | 14.5% | ||
| Q3 25 | 13.3% | 11.7% | ||
| Q2 25 | 14.1% | 12.6% | ||
| Q1 25 | -32.6% | 10.9% | ||
| Q4 24 | 16.2% | 16.3% | ||
| Q3 24 | 14.6% | 14.3% | ||
| Q2 24 | 9.3% | 12.4% | ||
| Q1 24 | 14.1% | 6.8% |
净利率MTXRVTY
| Q4 25 | 7.2% | 12.7% | ||
| Q3 25 | 8.1% | 6.7% | ||
| Q2 25 | 8.6% | 7.5% | ||
| Q1 25 | -29.3% | 6.4% | ||
| Q4 24 | 10.4% | 13.0% | ||
| Q3 24 | 8.9% | 13.8% | ||
| Q2 24 | 3.6% | 8.0% | ||
| Q1 24 | 8.7% | 4.0% |
每股收益（稀释后）MTXRVTY
| Q4 25 | $1.11 | $0.86 | ||
| Q3 25 | $1.37 | $0.40 | ||
| Q2 25 | $1.44 | $0.46 | ||
| Q1 25 | $-4.51 | $0.35 | ||
| Q4 24 | $1.67 | $0.77 | ||
| Q3 24 | $1.45 | $0.77 | ||
| Q2 24 | $0.61 | $0.45 | ||
| Q1 24 | $1.44 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $332.6M | $919.9M |
| 总债务越低越好 | $961.3M | — |
| 股东权益账面价值 | $1.7B | $7.3B |
| 总资产 | $3.5B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MTXRVTY
| Q4 25 | $332.6M | $919.9M | ||
| Q3 25 | $328.3M | $931.4M | ||
| Q2 25 | $319.9M | $991.8M | ||
| Q1 25 | $312.2M | $1.1B | ||
| Q4 24 | $337.1M | $1.2B | ||
| Q3 24 | $324.5M | $1.2B | ||
| Q2 24 | $316.4M | $2.0B | ||
| Q1 24 | $320.1M | $1.7B |
总债务MTXRVTY
| Q4 25 | $961.3M | — | ||
| Q3 25 | $964.3M | — | ||
| Q2 25 | $965.6M | — | ||
| Q1 25 | $966.7M | — | ||
| Q4 24 | $966.1M | — | ||
| Q3 24 | $922.9M | — | ||
| Q2 24 | $922.4M | — | ||
| Q1 24 | $925.8M | — |
股东权益MTXRVTY
| Q4 25 | $1.7B | $7.3B | ||
| Q3 25 | $1.7B | $7.4B | ||
| Q2 25 | $1.7B | $7.6B | ||
| Q1 25 | $1.6B | $7.6B | ||
| Q4 24 | $1.7B | $7.7B | ||
| Q3 24 | $1.7B | $7.9B | ||
| Q2 24 | $1.7B | $7.9B | ||
| Q1 24 | $1.7B | $7.8B |
总资产MTXRVTY
| Q4 25 | $3.5B | $12.2B | ||
| Q3 25 | $3.5B | $12.1B | ||
| Q2 25 | $3.5B | $12.4B | ||
| Q1 25 | $3.4B | $12.4B | ||
| Q4 24 | $3.4B | $12.4B | ||
| Q3 24 | $3.4B | $12.8B | ||
| Q2 24 | $3.3B | $13.4B | ||
| Q1 24 | $3.3B | $13.4B |
负债/权益比MTXRVTY
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.58× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 0.60× | — | ||
| Q4 24 | 0.55× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $64.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $31.9M | $161.8M |
| 自由现金流率自由现金流/营收 | 6.1% | 21.0% |
| 资本支出强度资本支出/营收 | 6.2% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.73× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $86.6M | $509.4M |
8季度趋势，按日历期对齐
经营现金流MTXRVTY
| Q4 25 | $64.3M | $182.0M | ||
| Q3 25 | $70.9M | $138.5M | ||
| Q2 25 | $62.9M | $134.3M | ||
| Q1 25 | $-4.4M | $128.2M | ||
| Q4 24 | $70.4M | $174.2M | ||
| Q3 24 | $60.0M | $147.9M | ||
| Q2 24 | $50.1M | $158.6M | ||
| Q1 24 | $55.9M | $147.6M |
自由现金流MTXRVTY
| Q4 25 | $31.9M | $161.8M | ||
| Q3 25 | $43.6M | $120.0M | ||
| Q2 25 | $33.8M | $115.5M | ||
| Q1 25 | $-22.7M | $112.2M | ||
| Q4 24 | $42.3M | $149.8M | ||
| Q3 24 | $35.3M | $125.6M | ||
| Q2 24 | $29.9M | $136.6M | ||
| Q1 24 | $39.4M | $129.7M |
自由现金流率MTXRVTY
| Q4 25 | 6.1% | 21.0% | ||
| Q3 25 | 8.2% | 17.2% | ||
| Q2 25 | 6.4% | 16.0% | ||
| Q1 25 | -4.6% | 16.9% | ||
| Q4 24 | 8.2% | 20.5% | ||
| Q3 24 | 6.7% | 18.4% | ||
| Q2 24 | 5.5% | 19.7% | ||
| Q1 24 | 7.4% | 20.0% |
资本支出强度MTXRVTY
| Q4 25 | 6.2% | 2.6% | ||
| Q3 25 | 5.1% | 2.6% | ||
| Q2 25 | 5.5% | 2.6% | ||
| Q1 25 | 3.7% | 2.4% | ||
| Q4 24 | 5.4% | 3.4% | ||
| Q3 24 | 4.7% | 3.3% | ||
| Q2 24 | 3.7% | 3.2% | ||
| Q1 24 | 3.1% | 2.7% |
现金转化率MTXRVTY
| Q4 25 | 1.73× | 1.85× | ||
| Q3 25 | 1.65× | 2.97× | ||
| Q2 25 | 1.39× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 1.30× | 1.84× | ||
| Q3 24 | 1.28× | 1.57× | ||
| Q2 24 | 2.54× | 2.87× | ||
| Q1 24 | 1.20× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTX
| High Temperature Technologies | $178.0M | 34% |
| Specialty Additives | $141.8M | 27% |
| Household And Personal Care | $132.5M | 26% |
| Environmental And Infrastructure | $67.2M | 13% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
